Effects of Collagen Peptide Supplementation on Muscle and Tendon Damage and Function
A Randomized Double-blinded Placebo-controlled Study to Evaluate the Effect of Collagen Peptide (Collagen Peptan) Supplementation on Muscle and Tendon Damage, Repair, and Functional Capacity During Exercise Training Overload
1 other identifier
interventional
22
1 country
1
Brief Summary
The aim of the study is to investigate the acute and short-term effects of collagen peptides (Collagen Peptan) on muscle and connective tissue during an eccentric overload training period. Currently, all studies investigating the effects of post-exercise collagen supplementation did this in the absence of whey proteins, which are part of the standard recommendations for post-exercise recovery. The investigators will therefore investigate whether the combined intake of whey proteins and collagen peptides ensures a better recovery of exercise performance and whether it can prevent or reduce symptoms of muscle and tendon overload during a three-week eccentric overload training period (n = 22).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Apr 2021
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 12, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 30, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2021
CompletedFirst Submitted
Initial submission to the registry
August 3, 2021
CompletedFirst Posted
Study publicly available on registry
June 21, 2022
CompletedJune 21, 2022
June 1, 2022
2 months
August 3, 2021
June 16, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Change in countermovement jump performance
Change in jump height when performing a countermovement jump, measured via a force platform
Pretest - 48 hours after the first training session (day 3 of training intervention) - Posttest (day 22 of training intervention)
Change in maximal isometric knee-extension force of the right leg
Change in maximal isometric knee-extension force (angle = 45°) of the right leg
Pretest - 48 hours after the first training session (day 3 of training intervention) - Posttest (day 22 of training intervention)
Change in anteroposterior thickness of the right patellar tendon
Change in anteroposterior thickness of the right patellar tendon
Pretest - 48 hours after the first training session (day 3 of training intervention) - Posttest (day 22 of training intervention)
Change in neovascularization of the right patellar tendon
Neovascularization of the right patellar tendon scored with the Modified Ohberg Score (range 0 - 4; the higher the score, the higher the degree of neovascularization).
Pretest - 48 hours after the first training session (day 3 of training intervention) - Posttest (day 22 of training intervention)
Secondary Outcomes (5)
Change in pain perception at the muscular level (VAS scale)
Training 1 (day 1 of training intervention) - Training 2 (day 3 of training intervention) - Training 8 (day 9 of training intervention) - Training 17 (day 19 of training intervention) - Posttest (day 22 of training intervention)
Change in pain perception of the patellar tendon of the right leg (VISA-P)
Pretest - Training 1 (day 1 of training intervention) - Training 17 (day 21 of training intervention) - Posttest (day 22 of training intervention)
Change in the blood concentration of creatine kinase
Pretest - Training 2 (day 3 of training intervention) - Posttest (day 22 of training intervention)
Change in the blood concentration of Interleukin 6 (IL-6)
Pretest - Training 2 (day 3 of training intervention) - Posttest (day 22 of training intervention)
Change in the blood concentration of N-terminal propeptide of type I procollagen (P1NP)
Pretest - Training 2 (day 3 of training intervention) - Posttest (day 22 of training intervention)
Study Arms (2)
Placebo
PLACEBO COMPARATOROnly whey protein will be provided
Collagen
EXPERIMENTALA mix of whey protein and collagen peptides will be provided
Interventions
Daily 45g of whey protein supplementation during a three week eccentric training period
Daily 15g of whey protein and 20g collagen peptide supplementation during a three week eccentric training period
Eligibility Criteria
You may qualify if:
- Sports participation, including general fitness training, between 2 and 5 hours max per week
- Body mass index between 18.5 and 25
You may not qualify if:
- Any kind of injury/pathology that is a contra-indication to perform high-intensity exercise - Intake of any medication or nutritional supplement that could impact muscle protein synthesis and/or exercise performance during the period of the study
- Intake of any whey protein, casein of branched-chain amino acid (BCAA) supplements from 1 month prior to the start of the study
- Blood donation within 3 months prior to the start of the study
- Smoking
- Current participation in another research trial
- Any other argument to believe that the subject is unlikely to successfully complete the full study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- KU Leuvenlead
- Rousselot BVBAcollaborator
Study Sites (1)
Exercise Physiology Research Group
Leuven, Vlaams-Brabant, 3001, Belgium
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
August 3, 2021
First Posted
June 21, 2022
Study Start
April 12, 2021
Primary Completion
May 30, 2021
Study Completion
June 30, 2021
Last Updated
June 21, 2022
Record last verified: 2022-06